Análisis Argos
PRVA
PRVACara
Privia Health Group, Inc. · Healthcare
US$ 24.83
precio al 2026-07-28
Valor justo Argos*
US$ 16–17
vs. su valor justo
42% por encima
Score Argos
56/100
LA RESPUESTA
El mercado le pide crezca 25.9% al año — más de lo que ha demostrado (10%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Las ganancias crecieron 59% el último año.
Tiene más caja que deuda: balance fuerte.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Venta significativa de insiders en el último trimestre.
VALOR1/6FUTURO4/6PASADO3/6SALUD5/6DIVIDENDO1/6
El Iris de calidad
VALOR1/6FUTURO4/6PASADO3/6SALUD5/6DIVIDENDO1/6
ValorCotiza por encima de su valor justo
FuturoIngresos creciendo con fuerza
PasadoHistorial aceptable
SaludBalance fuerte, deuda controlada
DividendoEl dividendo aún duerme
Score Argos56de 100Cara
Ingresos22%
US$ 2.1 B
Margen operativo60%
1.6%
Flujo de caja libre60%
US$ 0.2 B
Deuda neta
US$ -0.5 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 3.1B
P/E136.5x
EV/EBITDA60.2x
FCF yield5.2%
ROIC8.7%
Margen operativo1.6%
Crecim. ingresos+22.3%/año
Piotroski F6/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

fool.com · 12 jul
What Does a Privia Health Insider's Sale of Company Shares for $3.6 Million Mean for Investors?
Former CEO Shawn Morris sold 135,498 shares on June 30 and July 1, 2026, generating proceeds of ~$3.57 million at a weighted average price around $26.32 per share. Morris' sale reduced direct ownership to 76,651 shares post-transaction.
globenewswire.com · 7 jul
Privia Health to Report Second Quarter 2026 Results on Thursday, August 6
ARLINGTON, Va., July 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods ended June 30, 2026 before market open on Thursday, August 6, 2026.
fool.com · 8 jun
Privia's CEO Just Sold 121,000 Shares for $2.7 Million
CEO Parth Mehrotra sold 121,086 shares directly for a total of ~$2.73 million at an average price of around $22.56 per share across two days ending May 12, 2026. This transaction represented 21.80% of Mehrotra's direct holdings prior to the sale, reducing his direct position to 434,357 shares.
gurufocus.com · 4 jun
A Look at Privia Health Group Inc (PRVA) After 3.4% Gain -- GF Value $27.19 vs Price $21.37
On June 04, 2026, Privia Health Group Inc (PRVA) shares rose 3.4% to a current price of $21.37. Over the past 52 weeks, the stock has traded between $18.77 and
fool.com · 30 may
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?
Privia Health Group delivers technology-driven solutions to optimize physician practices and support value-based care nationwide.
globenewswire.com · 28 may
Cross Keys Capital Advises Neurology Group of Bergen County in Its Partnership with Privia Health
Fort Lauderdale, May 28, 2026 (GLOBE NEWSWIRE) -- Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to physician group practices and healthcare services companies,is  pleased to announce it acted as the exclusive financial advisor to the Neurology Group of Bergen County (“NGBC”) in its partnership with Privia Health. Founded in 1973, the Neurology Group of Bergen County is one of the region's most respected independent neurology practices, serving the communities of Bergen County, New Jersey.
zacks.com · 27 may
TBRG vs. PRVA: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Info Systems sector might want to consider either TruBridge (TBRG) or Privia Health (PRVA). But which of these two stocks presents investors with the better value opportunity right now?
globenewswire.com · 27 may
Privia Health Enters New Jersey
ARLINGTON, Va., May 27, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), a national physician enablement company, announced it has signed a definitive agreement to enter the state of New Jersey in partnership with Neurology Group of Bergen County (NGBC), a practice with 25 adult and pediatric clinicians.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.